---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-24-000015"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2024-02-22T23:59:59+00:00"
generated_at: "2026-06-05T19:29:03.814296+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst Q4 rev $75.1M (+9% YoY), FY rev $295.9M; CFO Hunt resigns, Alger named CFO; guides 2024 rev $304-312M

## Summary
- Q4 total revenue $75.1M, up 9% YoY; net loss $30.3M; adjusted EBITDA $1.4M (in line with guidance midpoint).
- FY2023 total revenue $295.9M, beat guidance midpoint; net loss $118.1M; adjusted EBITDA $11.0M (in line with guidance).
- 2024 guidance: revenue $304-312M; adjusted EBITDA $24-26M (~125%+ YoY growth at midpoint).
- CFO Bryan Hunt resigns effective March 1, replaced by CAO Jason Alger; Dan LeSueur appointed COO effective same date.
- Director Mark Templeton resigns effective March 1; 13,405 RSUs accelerated vesting; no disagreement cited.

## SEC filing metadata
- accession: 0001636422-24-000015
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2024-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000015/0001636422-24-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000015/hcat-20240216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-24-000015
- JSON: https://secwatch.observer/filing/0001636422-24-000015.json
- Plain text: https://secwatch.observer/filing/0001636422-24-000015.txt

## Key facts
- Earnings Releases
  Health Catalyst, Inc. updated its the quarter and year ended December 31, 2023 guidance (reaffirmed).
  - Period: the quarter and year ended December 31, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On February 22, 2024, Health Catalyst, Inc. (the Company) issued a press release relating to its financial results for the quarter and year ended December 31, 2023. A copy of the press release, the summary of the Company's 2023 Financial Highlights, 2024 Guidance & Key Themes, and the summary of the Company’s Updated Growth and Financial Targets are attached hereto as Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3, respectively, and each are incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000015/0001636422-24-000015-index.htm
- Executive change
  Jason Alger was appointed as Chief Financial Officer at Health Catalyst, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On February 22, 2024, the Company announced that Jason Alger, age 40, the Company’s Chief Accounting Officer and principal accounting officer, will assume the role of Chief Financial Officer and principal financial officer of the Company, effective March 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000015/0001636422-24-000015-index.htm
- Executive change
  Bryan Hunt resigned as Chief Financial Officer at Health Catalyst, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On February 16, 2024, Bryan Hunt informed the board of directors of the Company (the Board) of, and on February 20, 2024, the Board accepted, his resignation as the Company's Chief Financial Officer and principal financial officer, effective March 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000015/0001636422-24-000015-index.htm
- Executive change
  Daniel LeSueur was appointed as Chief Operating Officer at Health Catalyst, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On February 22, 2024, the Company announced that Daniel LeSueur, age 45, the Company’s Senior Vice President and General Manager of the Professional Services Business Unit, will assume the role of Chief Operating Officer and principal operating officer of the Company, effective March 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000015/0001636422-24-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.